H3 molecular stereochemistry
Work through stereochemical projections, conformations, configurations, optical activity and transition-metal stereochemistry, with focused practice.
Offline pages
Saved on this device only. Connect at least once every 30 days to confirm Premium. Sign-out or a change of account removes saved copies.
Before you begin
Stereochemistry is about the three-dimensional shapes of molecules. This topic starts with reading and drawing projections, then covers conformations and their energies, cis/trans and E/Z isomers, R and S configurations, optical activity and optical purity, and finishes with the stereoisomers of complex ions.
Be comfortable with: isomerism and stereochemistry, complex ions and ligands, and tetrahedral, square-planar and octahedral shapes.
Learning goals
- Use Newman and other stereochemical projections
- Interpret stereochemical projections
- Explain conformational isomerism and rotational barriers
- Assign cis/trans and E/Z configurations
- Apply R/S, optical activity and optical-purity reasoning
- Identify cis/trans isomerism in square-planar and octahedral complexes
- Identify enantiomerism in octahedral complexes
Syllabus statements covered
- use stereochemical projections, including Newman projections, to represent molecules
- interpret stereochemical projections of molecules [knowledge of Fischer projections is not required]
- apply their understanding of the following types of isomerism to explain the stereochemistry of molecules, including saturated ring systems: — conformational isomerism, including energy barriers to rotation and interconversion
- apply their understanding of the following types of isomerism to explain the stereochemistry of molecules, including saturated ring systems: — cis-trans isomerism, including E, Z nomenclature
- apply their understanding of the following types of isomerism to explain the stereochemistry of molecules, including saturated ring systems: — enantiomerism and diastereomerism - R, S configuration - optical activity optical purity as the excess of one enantiomer, including calculation of optical purity by the equation: [α ]obs optical purity = × 100% [α ]pure material
- recognise that transition element complexes can also exhibit stereoisomerism: — cis-trans isomerism, e.g. square planar complexes such as [Pt(NH3)2Cl2] and octahedral complexes such as [Co(NH3)4(H2O)2]2+
- recognise that transition element complexes can also exhibit stereoisomerism: — enantiomerism, e.g. [Ni(H2NCH2CH2NH2)3]2+ and [Ni(H2NCH2CH2NH2)2(H2O)2]2+ [identification of fac-mer isomerism is not required]
Lessons
Work through them in order.
2.1 Molecular Stereochemistry
- Use Newman and other stereochemical projectionsRedraw a molecule as wedge–dash, sawhorse and Newman projections without changing its structure.
- Interpret stereochemical projectionsRead wedge–dash, sawhorse and Newman drawings to recover connectivity and 3D arrangement.
- Explain conformational isomerism and rotational barriersExplain the conformations of ethane, butane and cyclohexane and the energy barriers between them.
- Assign cis/trans and E/Z configurationsAssign cis/trans and E/Z configurations, ranking the groups on each double-bond carbon.
- Assign R/S and compare stereoisomersAssign R or S to a chiral centre, and reason about optical activity and optical purity.
- Calculate optical purity and enantiomeric excessUse a matched pure-enantiomer reference to find the excess enantiomer and convert optical purity into mixture composition.
- Identify cis/trans isomerism in square-planar and octahedral complexesIdentify cis/trans isomers of square-planar and octahedral complexes from ligand positions.
- Identify enantiomerism in octahedral complexesDecide whether an octahedral complex has non-superimposable mirror images.
Practise and check
Or choose
Topic reference
Quick reference
| Question | First move | What to show |
|---|---|---|
| Draw a Newman projection | state the bond you look along; front carbon is the point, rear carbon the circle | each group on its own carbon; the dihedral angle |
| Rank conformers | staggered or eclipsed; then how close the large groups are | anti < gauche < eclipsed |
| Cyclohexane ring flip | swap axial and equatorial | up stays up; large groups prefer equatorial |
| Assign E/Z | rank the two groups on each alkene carbon by CIP | winners together: Z; opposite: E |
| Assign R/S | rank all four groups; point group 4 away | 1 → 2 → 3 clockwise: R; anticlockwise: S |
| Optical purity | [α]_obs/[α]ₚᵤᵣₑ × 100% | the excess; major = (100 + e)/2 % |
| Cis/trans complex | identify the shape; compare one pair of identical ligands | 90°: cis; 180°: trans |
| Chiral complex? | draw the mirror image, keeping each bidentate ligand intact | can it be superimposed by rotation? |
Core knowledge to remember
- Conformers interconvert by rotation about single bonds; configurations change only if bonds are broken.
- In a Newman projection, staggered bonds are 60° apart and eclipsed bonds 0°; anti is a dihedral angle of 180° and gauche 60°.
- A cyclohexane ring flip swaps axial and equatorial positions but keeps up and down.
- E/Z and R/S use Cahn–Ingold–Prelog priorities: higher atomic number at the first point of difference wins.
- Enantiomers are non-superimposable mirror images; diastereomers are stereoisomers that are not mirror images. A meso compound has stereocentres but is achiral.
- R and S do not predict the sign of optical rotation. A racemic mixture has no optical rotation.
- Square-planar [Pt(NH₃)₂Cl₂] and octahedral [Co(NH₃)₄(H₂O)₂]²⁺ have cis/trans isomers; [Ni(en)₃]²⁺ and cis-[Ni(en)₂(H₂O)₂]²⁺ have enantiomers.
Common mistakes
- Moving a group from one carbon to the other when redrawing a projection.
- Saying a ring flip moves a substituent to the other face of the ring.
- Ranking groups by size or chain length instead of CIP priority.
- Reading R/S without first pointing the lowest-priority group away.
- Assuming that R means (+) rotation.
- Taking the optical purity as the percentage of the major enantiomer.
- Calling a complex chiral without testing its whole mirror image, with the bidentate ligands kept intact.